Clinical Trial

Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Study acronym: GI-07
Recruiting
View on ClinicalTrials.gov →
Summary
Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-23
Trial Details
NCT Number NCT07647250
Lead Sponsor University of Illinois at Chicago
Conditions Physiological Reactivity to Cues, Physical Exercise
Enrollment 25 participants
Start Date 2026-06-22
Primary Completion 2031-04-30 (estimated)
Study Completion 2032-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-24